PLACE IN THERAPY: (when should it be used and who is a good candidate for this therapy; who should NOT receive this therapy)
(Prevention vs. Treatment)
Calcitonin
Additional Comments
Product names of drugs studied
Dosing considerations
Contraindications
Side effects
Monitoring for toxicity (as applicable)
MONITORING FOR EFFICACY: - Subjective:
- Objective:
BENEFIT OF THERAPY (Patient Oriented Outcomes):
PLACE IN THERAPY: (when should it be used and who is a good candidate for this therapy; who should NOT receive this therapy)
(Prevention vs. Treatment)
Parathyroid Hormones
Additional Comments
Product names of drugs studied
Dosing considerations
Contraindications
Side effects
Monitoring for toxicity (as applicable)
MONITORING FOR EFFICACY: - Subjective:
- Objective:
Citations:
(Cite at least two websites and one clinical trial with POEM level data. Provide a link to each website and the abstract of each study. You are encourage to upload relevant resources into the Wiki)
PLACE IN THERAPY: (when should it be used and who is a good candidate for this therapy; who should NOT receive this therapy)
(Prevention vs. Treatment)
MONITORING FOR EFFICACY:
- Subjective:
- Objective:BENEFIT OF THERAPY (Patient Oriented Outcomes):
PLACE IN THERAPY: (when should it be used and who is a good candidate for this therapy; who should NOT receive this therapy)
(Prevention vs. Treatment)
MONITORING FOR EFFICACY:
- Subjective:
- Objective:Citations:
(Cite at least two websites and one clinical trial with POEM level data. Provide a link to each website and the abstract of each study. You are encourage to upload relevant resources into the Wiki)